DoW Prostate Cancer Data Science Award
This grant funds research using data science methods like AI, bioinformatics, and computational analysis to study large prostate cancer datasets, requiring collaboration and alignment with key program challenges.
Funder: Dept. of the Army -- USAMRAA
Due Dates: August 12, 2026 (Pre-Application/LOI) | September 2, 2026 (Full Application) | September 8, 2026 (End of Verification Period)
Funding Amounts: ~$5.6M total; up to $1.4M per award (direct + indirect), max 3 years; ~4 awards expected.
Summary: Supports research leveraging data science, AI/ML, and quantitative methods to address key challenges in prostate cancer using large or complex datasets.
Key Information: Clinical trials, animal studies, and new dataset creation are not allowed; must address an FY26 PCRP Overarching Challenge.
Description
This opportunity supports research that develops or applies quantitative and analytical approaches—including artificial intelligence, machine learning, bioinformatics, computational biology, digital pathology, and related fields—to obtain knowledge and insight from large and/or complex datasets relevant to prostate cancer. Projects must address at least one of the FY26 Prostate Cancer Research Program (PCRP) Overarching Challenges, such as improving survivorship, developing/improving treatments for lethal prostate cancer, enhancing clinical care, or defining the biology of lethal progression. The mechanism allows for multiple Principal Investigators (PIs) and encourages multidisciplinary collaborations, especially between data scientists and clinicians.
Distinctive features:
- Multiple PI option: Initiating and Partnering PIs submit separate but linked applications.
- Projects must use existing datasets; development of new datasets and clinical trials are not permitted.
- Open sharing of tools, resources, and computational processes is expected.
